Alkermes Faces Legal Scrutiny Over Patent Claims in Vivitrol Lawsuit
In a recent development, Alkermes PLC faces significant legal hurdles after a Massachusetts federal judge allowed most claims in a proposed class action lawsuit concerning the company’s addiction treatment drug, Vivitrol. The case has raised serious questions about the integrity of the patent process following allegations that Alkermes intentionally omitted a key study from its…